1. Activity and safety of nivolumab, an anti-PD-1 immune checkpoint inhibitor, for patients with advanced, refractory squamous non-small-cell lung cancer (CheckMate 063): a phase 2, single-arm trial. Issue 3 (March 2015) Authors: Rizvi, Naiyer A; Mazières, Julien; Planchard, David; Stinchcombe, Thomas E; Dy, Grace K; Antonia, Scott J; Horn, Leora; Lena, Hervé; Minenza, Elisa; Mennecier, Bertrand; Otterson, Gregory A; Campos, Luis T; Gandara, David R; Levy, Benjamin P; Nair, Suresh G; Zalcman, Gérard; Wolf, Jürgen; Souquet... Journal: Lancet oncology Issue: Volume 16:Issue 3(2015:Mar.) Page Start: 257 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Activity and safety of nivolumab, an anti-PD-1 immune checkpoint inhibitor, for patients with advanced, refractory squamous non-small-cell lung cancer (CheckMate 063): a phase 2, single-arm trial. Issue 3 (March 2015) Authors: Rizvi, Naiyer A; Mazières, Julien; Planchard, David; Stinchcombe, Thomas E; Dy, Grace K; Antonia, Scott J; Horn, Leora; Lena, Hervé; Minenza, Elisa; Mennecier, Bertrand; Otterson, Gregory A; Campos, Luis T; Gandara, David R; Levy, Benjamin P; Nair, Suresh G; Zalcman, Gérard; Wolf, Jürgen; Souquet... Journal: Lancet oncology Issue: Volume 16:Issue 3(2015:Mar.) Page Start: 257 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Clinical characteristics, time course, treatment and outcomes of patients with immune checkpoint inhibitor-associated myocarditis. Issue 6 (23rd June 2021) Authors: Puzanov, Igor; Subramanian, Poornima; Yatsynovich, Yan V; Jacobs, David M; Chilbert, Maya R; Sharma, Umesh C; Ito, Fumito; Feuerstein, Steven G; Stefanovic, Filip; Switzer, Benjamin; Hicar, Mark D; Curtis, Anne B; Spangenthal, Edward J; Dy, Grace K; Ernstoff, Marc S; Vachhani, Pankit; Page, Brian... Journal: Journal for immunotherapy of cancer Issue: Volume 9:Issue 6(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Risk and benefit of neoadjuvant therapy among patients undergoing resection for non-small-cell lung cancer. (13th December 2017) Authors: Yendamuri, Sai; Groman, Adrienne; Miller, Austin; Demmy, Todd; Hennon, Mark; Dexter, Elisabeth; Picone, Anthony; Nwogu, Chukwumere; Dy, Grace K Journal: European journal of cardio-thoracic surgery Issue: Volume 53:Number 3(2018) Page Start: 656 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗